Loading
Life sciences · Journal article
Aggregate · September 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Phototherapy has become a significant research direction in tumor therapy owing to its high spatial selectivity, low systemic toxicity, and excellent biocompatibility. In recent years, diverse strategies including photodynamic therapy (PDT), photothermal therapy (PTT), photoimmunotherapy (PIT), and photogas therapy (PGT) have been extensively developed, accompanied by remarkable advances in the structural design and energy conversion mechanisms of photosensitive materials. However, current phototherapy research still lacks a material‐design‐guided photoresponsive conversion framework and development trends across different therapeutic modalities remain insufficiently understood, which limits the rational design and multimechanism collaborative optimization of photosensitizers. Herein, this review systematically summarizes the latest research progress and material evolution trends in phototherapy. The discussion focuses on structural principles governing light‐to‐heat conversion in PTT, reactive oxygen species generation in PDT, immune activation in PIT, and light‐triggered gas release in PGT. Current limitations such as insufficient light penetration, potential toxicity, poor clearance and translational challenges are further discussed. This review aims to provide design guidance for developing efficient, controllable, and clinically translatable photoresponsive materials for cancer phototherapy.